Development and Validation of a Prognostic Model for Cervical Cancer Based on Chlamydia trachomatis-Associated Transcriptional Signatures. (PubMed, Int J Womens Health) - Jul 15, 2026 - "Drug sensitivity analysis identified BI-2536, SB505124, and Sepantronium bromide as potential therapeutic agents for high-risk patients. We established a novel prognostic model for CESC based on CT-related genes in an HPV-positive CESC background, which provides new insights into CT infection-associated immune regulation in CESC and individualized immunotherapy and targeted treatment strategies."
IO biomarker • Journal • Cervical Adenocarcinoma • Cervical Cancer • Cervical Squamous Cell Carcinoma • Infectious Disease • Oncology • Solid Tumor • Squamous Cell Carcinoma • CD4
|
|
Cong You; Hao Zhao; Lang Xie; Mei Wang; Shiyin Xiong; Xiufeng Qiu; Zhengrui Hu
|